The cyclophilin inhibitor CRV431 inhibits liver HBV DNA and HBsAg in transgenic mice

Hepatitis B virus (HBV) infection is a major health burden worldwide with 240 million chronically infected individuals. Nucleos(t)ide analogs and interferons are the current standards of care due to their suppression of HBV replication, but the treatments rarely eradicate HBV from individuals. Simil...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallay, Philippe, Ure, Daren, Bobardt, Michael, Chatterji, Udayan, Ou, James, Trepanier, Daniel, Foster, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557616/
https://www.ncbi.nlm.nih.gov/pubmed/31181107
http://dx.doi.org/10.1371/journal.pone.0217433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557616/
https://www.ncbi.nlm.nih.gov/pubmed/31181107
http://dx.doi.org/10.1371/journal.pone.0217433

Ejemplares similares